Clinical Study
Hypovitaminosis D in Patients with Type 2 Diabetes Mellitus: A Relation to Disease Control and Complications
Table 2
Anthropometric, biochemical characteristics, and parameters of diabetes control in diabetic patients according to 25 (OH) vitamin D level.
| | | 25 (OH) vitamin D < 20 ng/mL
() | 25 (OH) vitamin D ≥ 20 ng/mL
() | value* |
| | Age (years) | 57.6 (11.2) | 61.2 (11.1) | NS | | Height (cm) | 162.0 (9.1) | 163.6 (10.5) | NS | | Weight (kg) | 85.5 (15.1) | 79.7 (14.8) | 0.03 | | BMI (kg/m2) | 31.6 (5.1) | 29.6 (5.1) | 0.05 | | Systolic BP (mm Hg) | 136.5 (20.7) | 135.6 (25.3) | NS | | Diastolic BP (mm Hg) | 79.2 (13.0) | 78.2 (12.0) | NS | | Duration of diabetes | 8.4 (7.7) | 8.8 (6.9) | NS | | HbA1c (%) | 8.0 (1.6) | 7.5 (1.5) | 0.04 | | FBS (mg/dL) | 165.5 (65.5) | 160.1 (62.1) | NS | | Total cholesterol (mg/dL) | 179.2 (46.7) | 188.1 (66.5) | NS | | HDL (mg/dL) | 43.4 (11.1) | 45.9 (13.9) | NS | | LDL (mg/dL) | 110.4 (38.9) | 109.2 (35.2) | NS | | Triglyceride (mg/dL) | 175.4 (87.8) | 143.5 (59.5) | NS | | CRP | 5.3 (6.7) | 5.0 (6.2) | NS | | Creatinine (mg/dL) | 0.7 (0.2) | 0.7 (0.2) | NS | | Microalbumin/creatinin (mg/g) | 34.5 (43.3) | 19.9 (26.5) | 0.04 | | Calcium (mg/dL) | 9.3 (0.4) | 9.3 (0.4) | NS | | Phosphorous (mg/dL) | 3.5 (0.5) | 3.5 (0.4) | NS | | Retinopathy | | | | | Yes | 31.2% | 12.0% | 0.01 | | No | 68.8% | 88.0% | | Nephropathy | | | | | Yes | 48.4% | 68.2% | 0.08 | | No | 51.6% | 31.8% | | Neuropathy | | | 0.004 | | Yes | 67.5% | 58.0% | | No | 32.5% | 42.0% | | History of hypertension | | | | | Yes | 85.0% | 84.0% | NS | | No | 15.0% | 14.0% | | History of dyslipidemia | | | | | Yes | 90.0% | 92.0% | NS | | No | 10.0% | 8.0% | | Smoking | | | | | Yes | 53.8% | 66.0% | NS | | No | 46.3% | 44.0% |
|
|
Values are mean (SD) or percentages, as appropriate.
*
value for difference between groups by -test or chi-square, as appropriate.
|
